It was found that Schisandrin A suppressed the levels of urea nitrogen and urinary albumin, reduced the release of inflammatory factors, inhibited the level of MDA activity, and increased the levels of SOD, CAT, and GHS in STZ-induced DN, which effectively ameliorated oxidative stress and inflammatory responses in the DN model. The gene discussed is SOD1; the disease is liver dysplastic nodule.